Breaking News

NextPharma Acquires Santen’s Tampere Mfg. Facility

Adds ophthalmology manufacturing and sterile blow, fill, seal technology to its portfolio

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NextPharma, a European contract development and manufacturing organization (CDMO), has acquired a manufacturing facility in Tampere, Finland from Santen SA.   The acquisition is expected to be completed in the summer of 2019. The companies are entering into a strategic partnership that will see NextPharma take over production of Santen products in the Tampere facility.   NextPharma will be taking over the fully staffed site with 181 employees involved in manufacturing and its support functio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters